BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29672195)

  • 1. Hypoxia-mediated miR-212-3p downregulation enhances progression of intrahepatic cholangiocarcinoma through upregulation of Rab1a.
    Hou P; Kang Y; Luo J
    Cancer Biol Ther; 2018; 19(11):984-993. PubMed ID: 29672195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-19b-3p facilitates the proliferation and epithelial-mesenchymal transition, and inhibits the apoptosis of intrahepatic cholangiocarcinoma by suppressing coiled-coil domain containing 6.
    Tang Y; Yang J; Wang Y; Tang Z; Liu S; Tang Y
    Arch Biochem Biophys; 2020 Jun; 686():108367. PubMed ID: 32315652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-590-3p suppresses epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma by inhibiting SIP1 expression.
    Zu C; Liu S; Cao W; Liu Z; Qiang H; Li Y; Cheng C; Ji L; Li J; Li J
    Oncotarget; 2017 May; 8(21):34698-34708. PubMed ID: 28423728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-424-5p represses the metastasis and invasion of intrahepatic cholangiocarcinoma by targeting ARK5.
    Wu J; Yang B; Zhang Y; Feng X; He B; Xie H; Zhou L; Wu J; Zheng S
    Int J Biol Sci; 2019; 15(8):1591-1599. PubMed ID: 31360102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of microRNA-193-3p inhibits the progression of intrahepatic cholangiocarcinoma cells by upregulating TGFBR3.
    Han YL; Yin JJ; Cong JJ
    Exp Ther Med; 2018 May; 15(5):4508-4514. PubMed ID: 29725386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FXR Acts as a Metastasis Suppressor in Intrahepatic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition.
    Lv B; Ma L; Tang W; Huang P; Yang B; Wang L; Chen S; Gao Q; Zhang S; Xia J
    Cell Physiol Biochem; 2018; 48(1):158-172. PubMed ID: 30001540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-129-2-3p directly targets Wip1 to suppress the proliferation and invasion of intrahepatic cholangiocarcinoma.
    Chen C; Jiang J; Fang M; Zhou L; Chen Y; Zhou J; Song Y; Kong G; Zhang B; Jiang B; Li H; Peng C; Liu S
    J Cancer; 2020; 11(11):3216-3224. PubMed ID: 32231727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circ_0000218 plays a carcinogenic role in colorectal cancer progression by regulating miR-139-3p/RAB1A axis.
    Pei FL; Cao MZ; Li YF
    J Biochem; 2020 Jan; 167(1):55-65. PubMed ID: 31598673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-655-3p inhibited proliferation and migration of ovarian cancer cells by targeting RAB1A.
    Zha JF; Chen DX
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3627-3634. PubMed ID: 31114987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UHRF1 is regulated by miR-124-3p and promotes cell proliferation in intrahepatic cholangiocarcinoma.
    Zhu M; Wei C; Lin J; Dong S; Gao D; Chen J; Zhao Y; Liu B
    J Cell Physiol; 2019 Nov; 234(11):19875-19885. PubMed ID: 30989656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway.
    Liu LZ; He YZ; Dong PP; Ma LJ; Wang ZC; Liu XY; Duan M; Yang LX; Shi JY; Zhou J; Fan J; Gao Q; Wang XY
    Oncotarget; 2016 Nov; 7(46):75210-75220. PubMed ID: 27655691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152.
    Zhang S; Xiao J; Chai Y; Du YY; Liu Z; Huang K; Zhou X; Zhou W
    Dig Dis Sci; 2017 Nov; 62(11):3050-3058. PubMed ID: 28921383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Pathogenesis and Regulation of the
    Hozaka Y; Seki N; Tanaka T; Asai S; Moriya S; Idichi T; Wada M; Tanoue K; Kawasaki Y; Mataki Y; Kurahara H; Ohtsuka T
    Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34199886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortalin promotes cell proliferation and epithelial mesenchymal transition of intrahepatic cholangiocarcinoma cells in vitro.
    Kang Q; Cai JB; Dong RZ; Liu LX; Zhang C; Zhang PF; Zou H; Xie N; Zhang L; Zhang XY; Song ZJ; Dong ZR; Hu MY; Huang XY; Zhang XW; Ke AW; Shi GM
    J Clin Pathol; 2017 Aug; 70(8):677-683. PubMed ID: 28096273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Non-Coding RNA-PAICC Promotes the Tumorigenesis of Human Intrahepatic Cholangiocarcinoma by Increasing YAP1 Transcription.
    Xia L; Chen X; Yang J; Zhu S; Zhang L; Yin Q; Hong Y; Chen H; Chen G; Li H
    Front Oncol; 2020; 10():595533. PubMed ID: 33552968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications.
    Zhang C; Liu LX; Dong ZR; Shi GM; Cai JB; Zhang PF; Ke AW; Yu JX; Zhou J; Fan J
    Tumour Biol; 2015 Mar; 36(3):1781-9. PubMed ID: 25391422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WAVE3 Induces EMT and Promotes Migration and Invasion in Intrahepatic Cholangiocarcinoma.
    Zhu Z; Chen W; Yin X; Lai J; Wang Q; Liang L; Wang W; Wang A; Zheng C
    Dig Dis Sci; 2016 Jul; 61(7):1950-60. PubMed ID: 26971088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma.
    Li H; Zhou ZQ; Yang ZR; Tong DN; Guan J; Shi BJ; Nie J; Ding XT; Li B; Zhou GW; Zhang ZY
    Hepatology; 2017 Jul; 66(1):136-151. PubMed ID: 28194813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated TRIM44 promotes intrahepatic cholangiocarcinoma progression by inducing cell EMT via MAPK signaling.
    Peng R; Zhang PF; Zhang C; Huang XY; Ding YB; Deng B; Bai DS; Xu YP
    Cancer Med; 2018 Mar; 7(3):796-808. PubMed ID: 29446253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.